search
Back to results

Pediatric Tonsillectomy Pain Reduction Study

Primary Purpose

Postoperative Pain

Status
Completed
Phase
Phase 3
Locations
United States
Study Type
Interventional
Intervention
lidocaine (1%) + bupivacaine (0.5%)
Normal saline
Lidocaine (1%) + Bupivacaine (0.5%) + Clonidine (25mcg)
Sponsored by
Vanderbilt University Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Postoperative Pain focused on measuring Tonsillectomy, Postoperative Pain, Clonidine, Anesthetics, Local

Eligibility Criteria

3 Years - 17 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age 3 - 17 years old
  • BMI < 35
  • Negative pregnancy test in female patients age 10 and older
  • Diagnosed with adenotonsillar hypertrophy, recurrent adenotonsillitis or upper airway obstruction and will be undergoing tonsillectomy alone or adenotonsillectomy

Exclusion Criteria:

  • Diagnosis of obstructive sleep apnea
  • Patient with peritonsillar abscess
  • Allergy to study medication
  • Any major systemic illness, genetic disorder or diagnosed syndrome
  • Bleeding disorder

Sites / Locations

  • Vanderbilt University Monroe Carrel Jr. Children's Hospital

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Placebo Comparator

Active Comparator

Experimental

Arm Label

Normal Saline

Lidocaine (1%) + Bupivacaine 0.5%

Lidocaine + Bupivacaine + Clondine

Arm Description

1.5 ml injection of Normal Saline into each tonsillar fossa pre-tonsillectomy

Submucosal injection of 1.5 mL Lidocaine (1%) + Bupivacaine 0.5% into the tonsillar fossa, pre-tonsillectomy

Submucosal injection of 1.5 mL Lidocaine 1% + Bupivacaine 0.5% + Clondine 25mcg into the tonsillar fossa, pre-tonsillectomy

Outcomes

Primary Outcome Measures

Total Number of Post-operative Doses of Analgesics.
The total number of intravenous fentanyl doses given PACU which will be compared between the three randomized groups (arms)

Secondary Outcome Measures

Median Number of Pain Medication Doses
The median number of intravenous fentanyl doses administered in the PACU due to pain
Total Time Until Discharge From Hospital.
Mean Visual Analog Scale Pain Number.
Visual analog pain scale range is 0-10 with 0=no pain and 10 = worst pain ever
Number and Percent of Participants Able to Tolerate Only Liquids
The number and percent of patients whose post-operative diet has advanced to liquids only on post-op days 1, 3, 5 & 7
Number and Percent of Participants Able to Tolerate Only a Soft Diet
The number and percent of patients whose post-operative diet has only advanced to a soft diet on post-operative days 1, 3, 5 & 7
Number and Percent of Participants Able to Tolerate a Regular Diet
The number and percent of patients whose post-operative diet has to a regular diet on post-operative days 1, 3, 5 & 7

Full Information

First Posted
May 8, 2008
Last Updated
June 5, 2017
Sponsor
Vanderbilt University Medical Center
search

1. Study Identification

Unique Protocol Identification Number
NCT00678379
Brief Title
Pediatric Tonsillectomy Pain Reduction Study
Official Title
Pediatric Tonsillectomy Pain Reduction Study, a Randomized, Placebo Controlled, Double-Blind Clinical Trial Using Clonidine and Local Anesthetics
Study Type
Interventional

2. Study Status

Record Verification Date
June 2017
Overall Recruitment Status
Completed
Study Start Date
April 2008 (undefined)
Primary Completion Date
November 2009 (Actual)
Study Completion Date
November 2009 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Vanderbilt University Medical Center

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Tonsillectomy is associated with a significant decrease quality of life in children secondary to pain, which is worsened with swallowing. The objective of the current study is to conduct a prospective, double-blind, placebo-controlled, randomized clinical trial using a pre-tonsillectomy infiltration of the tonsillar fossa comparing three treatment regimens in reducing post-tonsillectomy morbidity (i.e. pain, poor oral intake): 1) Placebo (saline injection) 2) bupivacaine (0.5%) + lidocaine (1%), 3) bupivacaine (0.5%) + lidocaine (1%) + clonidine (25 µg).
Detailed Description
Tonsillectomy is associated with a significant decrease quality of life in children secondary to pain, which is worsened with swallowing. Previous studies in the pediatric population have demonstrated a significant decrease in post-operative pain/morbidity when administering pain reduction medications into the tonsillar fossa prior to removal. While these studies have shown great promise, no large randomized trial of the most promising medications has been conducted. Because of this, many otolaryngologists do not administer intra-operative medications aimed at reducing post-operative pain. The objective of the current study is to conduct a prospective, double-blind, placebo-controlled, randomized clinical trial using a pre-tonsillectomy infiltration of the tonsillar fossa comparing three treatment regimens in reducing post-tonsillectomy morbidity (i.e. pain, poor oral intake): 1) Placebo (saline injection) 2) bupivacaine (0.5%) + lidocaine (1%), 3) bupivacaine (0.5%) + lidocaine (1%) + clonidine (25 µg).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Postoperative Pain
Keywords
Tonsillectomy, Postoperative Pain, Clonidine, Anesthetics, Local

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
120 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Normal Saline
Arm Type
Placebo Comparator
Arm Description
1.5 ml injection of Normal Saline into each tonsillar fossa pre-tonsillectomy
Arm Title
Lidocaine (1%) + Bupivacaine 0.5%
Arm Type
Active Comparator
Arm Description
Submucosal injection of 1.5 mL Lidocaine (1%) + Bupivacaine 0.5% into the tonsillar fossa, pre-tonsillectomy
Arm Title
Lidocaine + Bupivacaine + Clondine
Arm Type
Experimental
Arm Description
Submucosal injection of 1.5 mL Lidocaine 1% + Bupivacaine 0.5% + Clondine 25mcg into the tonsillar fossa, pre-tonsillectomy
Intervention Type
Drug
Intervention Name(s)
lidocaine (1%) + bupivacaine (0.5%)
Intervention Description
Submucosal injection of 1.5 mL into each tonsillar fossa prior to performing tonsillectomy. B - lidocaine (1%) + bupivacaine (0.5%)
Intervention Type
Drug
Intervention Name(s)
Normal saline
Intervention Description
Submucosal injection of 1.5 mL into each tonsillar fossa prior to performing tonsillectomy. A - normal saline
Intervention Type
Drug
Intervention Name(s)
Lidocaine (1%) + Bupivacaine (0.5%) + Clonidine (25mcg)
Intervention Description
Submucosal injection of 1.5 mL into each tonsillar fossa prior to performing tonsillectomy. C - lidocaine (1%) + bupivacaine (0.5%) + clonidine (25mcg)
Primary Outcome Measure Information:
Title
Total Number of Post-operative Doses of Analgesics.
Description
The total number of intravenous fentanyl doses given PACU which will be compared between the three randomized groups (arms)
Time Frame
Post-operative thru day 7
Secondary Outcome Measure Information:
Title
Median Number of Pain Medication Doses
Description
The median number of intravenous fentanyl doses administered in the PACU due to pain
Time Frame
in recovery room
Title
Total Time Until Discharge From Hospital.
Time Frame
Day of Surgery
Title
Mean Visual Analog Scale Pain Number.
Description
Visual analog pain scale range is 0-10 with 0=no pain and 10 = worst pain ever
Time Frame
in recovery room; post-operative days 1,3,5 & 7
Title
Number and Percent of Participants Able to Tolerate Only Liquids
Description
The number and percent of patients whose post-operative diet has advanced to liquids only on post-op days 1, 3, 5 & 7
Time Frame
post-operative days 1,3,5 & 7.
Title
Number and Percent of Participants Able to Tolerate Only a Soft Diet
Description
The number and percent of patients whose post-operative diet has only advanced to a soft diet on post-operative days 1, 3, 5 & 7
Time Frame
post-operative days 1,3,5 & 7.
Title
Number and Percent of Participants Able to Tolerate a Regular Diet
Description
The number and percent of patients whose post-operative diet has to a regular diet on post-operative days 1, 3, 5 & 7
Time Frame
post-operative days 1,3,5 & 7.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
3 Years
Maximum Age & Unit of Time
17 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age 3 - 17 years old BMI < 35 Negative pregnancy test in female patients age 10 and older Diagnosed with adenotonsillar hypertrophy, recurrent adenotonsillitis or upper airway obstruction and will be undergoing tonsillectomy alone or adenotonsillectomy Exclusion Criteria: Diagnosis of obstructive sleep apnea Patient with peritonsillar abscess Allergy to study medication Any major systemic illness, genetic disorder or diagnosed syndrome Bleeding disorder
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jonathan R Moss, MD, MPH
Organizational Affiliation
Vanderbilt University Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Vanderbilt University Monroe Carrel Jr. Children's Hospital
City
Nashville
State/Province
Tennessee
ZIP/Postal Code
37299
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Undecided
IPD Sharing Plan Description
No plan to share unless specifically requested within 5 year storage of data period.
Citations:
PubMed Identifier
17312203
Citation
Cucchiaro G, Ganesh A. The effects of clonidine on postoperative analgesia after peripheral nerve blockade in children. Anesth Analg. 2007 Mar;104(3):532-7. doi: 10.1213/01.ane.0000253548.97479.b8.
Results Reference
background
PubMed Identifier
16159655
Citation
Naja MZ, El-Rajab M, Kabalan W, Ziade MF, Al-Tannir MA. Pre-incisional infiltration for pediatric tonsillectomy: a randomized double-blind clinical trial. Int J Pediatr Otorhinolaryngol. 2005 Oct;69(10):1333-41. doi: 10.1016/j.ijporl.2005.03.020. Epub 2005 Apr 22.
Results Reference
background
PubMed Identifier
17720118
Citation
McCartney CJ, Duggan E, Apatu E. Should we add clonidine to local anesthetic for peripheral nerve blockade? A qualitative systematic review of the literature. Reg Anesth Pain Med. 2007 Jul-Aug;32(4):330-8. doi: 10.1016/j.rapm.2007.02.010.
Results Reference
background
PubMed Identifier
8436459
Citation
Jebeles JA, Reilly JS, Gutierrez JF, Bradley EL Jr, Kissin I. Tonsillectomy and adenoidectomy pain reduction by local bupivacaine infiltration in children. Int J Pediatr Otorhinolaryngol. 1993 Jan;25(1-3):149-54. doi: 10.1016/0165-5876(93)90048-8.
Results Reference
background
PubMed Identifier
1784501
Citation
Jebeles JA, Reilly JS, Gutierrez JF, Bradley EL Jr, Kissin I. The effect of pre-incisional infiltration of tonsils with bupivacaine on the pain following tonsillectomy under general anesthesia. Pain. 1991 Dec;47(3):305-308. doi: 10.1016/0304-3959(91)90220-R.
Results Reference
background
PubMed Identifier
11587610
Citation
Giannoni C, White S, Enneking FK, Morey T. Ropivacaine with or without clonidine improves pediatric tonsillectomy pain. Arch Otolaryngol Head Neck Surg. 2001 Oct;127(10):1265-70. doi: 10.1001/archotol.127.10.1265.
Results Reference
background
PubMed Identifier
21422302
Citation
Moss JR, Cofer S, Hersey S, Goudy S, Werkhaven J, Swanson E, Mantle C, Stowell N, Byrne D, Wang L, Labadie R. Comparison of clonidine, local anesthetics, and placebo for pain reduction in pediatric tonsillectomy. Arch Otolaryngol Head Neck Surg. 2011 Jun;137(6):591-7. doi: 10.1001/archoto.2011.45. Epub 2011 Mar 21.
Results Reference
derived

Learn more about this trial

Pediatric Tonsillectomy Pain Reduction Study

We'll reach out to this number within 24 hrs